Home > Endothelix Salary

Endothelix Salary

  • 66
  • 14
  • 53
Endothelix average salary is $100,000, median salary is $100,000 with a salary range from $100,000 to $100,000.
Endothelix salaries are collected from government agencies and companies. Each salary is associated with a real job position. Endothelix salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
100,000
Average
100,000
Median
100,000
High
100,000
Total 1 Endothelix Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Chief Medical Scientist 100,000-100,000 Dedham, MA, 02026 2016 Endothelix Chief Medical Scientist Salaries (1)
Endothelix Dedham, MA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Endothelix salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Endothelix Jobs
See more Endothelix Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
15

All Patents

0

Grant Patents

15

Patents Pending

10

Patents Families

More Recent
Endothelix... Information
  • Endothelix Inc
  • Industry: Medical Equipment
  • City: Houston, TX
  • Endothelix, Inc. is a cardiovascular device company focused on addressing the following two problems in a cost-effective manner:Inaccurate individualized prediction of cardiovascular risk Inadequate monitoring of the vascular response to treatments The company's first product is VENDYS?, a non-invasive, inexpensive, and easy to use vascular function test that aims to help physicians more accurately assess and monitor their patients' cardiovascular health and use appropriate therapies for the prevention and treatment of heart disease and stroke. The company originated in the Texas Medical Center-Houston from a collaborative project between the Texas Heart Institute and The University of Texas Health Science Center